AHA Coding Clinic® for HCPCS - 2017 Issue 4; For Your Information

Pass-through status granted to eight drugs and biologicals effective January 1, 2018

HCPCS Code Long Description C9014 Injection, cerliponase alfa, 1 mg C9015 Injection, c-1 esterase inhibitor (human), haegarda, 10 units C9016 Injection, triptorelin extended release, 3.75 mg C9024 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine C9028 Injection, inotuzumab ozogamicin, 0.1 mg C9029 Injection, guselkumab, 1 mg J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg J9203 Injection, gemtuzumab ozogamicin, 0.1 mg ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.